This observation may explain why semaglutide and other GLP-1 RAs ranked among the lowest-impact DM2 DMTs in our model compared to drugs such as metformin, which engage a broader range of metabolic and neuroprotective pathways (e.g., AMPK, insulin, and adipocytokine signaling)
It incorporates key modifications, including 14E/17R mutations to stabilize an -helical segment via a salt bridge, multiple proline substitutions (25P, 28P, 29P) to reduce -sheet formation, and N-terminal C20 fatty diacid lipidation for reversible albumin binding (Kruse et al
This represents a big step forward, as drug manufacturers have shied away from investing in research for adjunctive therapies in the past
Middle-aged and elderly adults are more prone to this condition, and it can occur at any age
Oxidative stress and autophagy: The clash between damage and metabolic needs